Preventive maintenance for 3D0120 laboratory analyzers
Ended Purchase Order Awarded Last action
- Contract number
- HT941025P0013
- Awardee
-
Biomerieux Japan LTD. UEI JZPDU6QCKX55
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $16,287
Award facts
- Contract value 59% obligated
-
- $16,286.95 Current, with exercised options
- $27,386.07 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Japan
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $10,752 | |
| Exercise an Option | $0 | |
| Original award | $5,535 |
About this award
The Defense Health Agency awarded a $27,386.07 firm fixed-price purchase order to Biomerieux Japan LTD. on November 1, 2024, for preventive maintenance services on two BioMérieux VIRTUO analyzers at United States Naval Hospital Yokosuka in Japan. The contract, which carries no set-aside designation, extends through September 30, 2027, and addresses critical laboratory diagnostic support for forward-deployed U.S. Navy medical personnel and eligible beneficiaries stationed in the Pacific region. Biomerieux Japan LTD., a Japanese subsidiary of the France-based BioMérieux SA biotechnology company, specializes in in vitro diagnostics and microbiological testing systems and is registered in SAM.gov.
This procurement represents a direct arrangement to maintain mission-critical laboratory equipment at an overseas military medical treatment facility. The 3D0120 VIRTUO analyzers perform essential microbiological testing functions necessary for clinical diagnostics at Naval medical installations. This award is part of a broader engagement between Biomerieux Japan LTD. and the Defense Health Agency, with the company holding three prime purchase order contracts valued at approximately $238.7K in aggregate, all supporting Navy Medicine laboratory capabilities at facilities in Japan through the supply of diagnostic consumables and equipment maintenance services.
Quick answers
Who was awarded contract HT941025P0013?
HT941025P0013 was awarded to Biomerieux Japan LTD. by Defense Health Agency (Department of Defense) on November 1, 2024.
How much is contract HT941025P0013 worth?
The government has obligated $16,287 on HT941025P0013. Its potential value, with all options, is $27,386.
Was contract HT941025P0013 competed?
The extent of competition for HT941025P0013 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award